OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10161-10161
Open Access | Times Cited: 46
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10161-10161
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 46
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 46
PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
Isaac Pérez-Segura, Alberto Santiago-Balmaseda, Luis Daniel Rodríguez-Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3264-3264
Open Access | Times Cited: 16
Isaac Pérez-Segura, Alberto Santiago-Balmaseda, Luis Daniel Rodríguez-Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3264-3264
Open Access | Times Cited: 16
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
Evaluating the Molecular Interactions between Type 2 Diabetes Mellitus and Parkinson’s Disease: Role of Antidiabetic Drugs as Promising Therapeutics
Irum Waheed, Talal Sikandri, Sumbal Zaheen, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Irum Waheed, Talal Sikandri, Sumbal Zaheen, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Uncovering Novel Therapeutic Targets for Parkinson’s Disease
Ritu Soni, Prashant Delvadia, Amit Joharapurkar, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 1935-1949
Closed Access | Times Cited: 11
Ritu Soni, Prashant Delvadia, Amit Joharapurkar, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 1935-1949
Closed Access | Times Cited: 11
Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson’s Disease
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 678-678
Open Access | Times Cited: 16
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 678-678
Open Access | Times Cited: 16
Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
Sanjay Sanjay, Anshul Sharma, Hae‐Jeung Lee
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1914-1914
Open Access | Times Cited: 21
Sanjay Sanjay, Anshul Sharma, Hae‐Jeung Lee
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1914-1914
Open Access | Times Cited: 21
Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review
Mahima Koshatwar, Sourya Acharya, Roshan Prasad, et al.
Cureus (2023)
Open Access | Times Cited: 8
Mahima Koshatwar, Sourya Acharya, Roshan Prasad, et al.
Cureus (2023)
Open Access | Times Cited: 8
Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review
Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176755-176755
Open Access | Times Cited: 2
Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176755-176755
Open Access | Times Cited: 2
Transforming Healthcare in the New AI Era through Integrated Personalized Healthcare
Neema Bisht, Zahraa Saad Abdulaaali Ali, Nizar Abdel Amir, et al.
(2024), pp. 790-794
Closed Access | Times Cited: 2
Neema Bisht, Zahraa Saad Abdulaaali Ali, Nizar Abdel Amir, et al.
(2024), pp. 790-794
Closed Access | Times Cited: 2
Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4565-4565
Open Access | Times Cited: 10
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4565-4565
Open Access | Times Cited: 10
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity
Anna Lauritano, Irene Cipollone, Roberta Verde, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 10
Anna Lauritano, Irene Cipollone, Roberta Verde, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 10
Exploring Perspectives, Issues, and Practices in the Testing and Quality Validation of AI Software
Mukta Jukaria, Saif O. Husain, Enas Muhsin, et al.
(2024), pp. 768-772
Closed Access | Times Cited: 1
Mukta Jukaria, Saif O. Husain, Enas Muhsin, et al.
(2024), pp. 768-772
Closed Access | Times Cited: 1
Impact of natural compounds on peroxisome proliferator-activated receptor: Molecular effects and its importance as a novel therapeutic target for neurological disorders
Zhe Zhu, Yu Guan, Songlan Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117170-117170
Closed Access | Times Cited: 1
Zhe Zhu, Yu Guan, Songlan Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117170-117170
Closed Access | Times Cited: 1
Optimizing repair of tendon ruptures and chronic tendinopathies: Integrating the use of biomarkers with biological interventions to improve patient outcomes and clinical trial design
David A. Hart, Aisha Ahmed, Paul W. Ackermann
Frontiers in Sports and Active Living (2023) Vol. 4
Open Access | Times Cited: 4
David A. Hart, Aisha Ahmed, Paul W. Ackermann
Frontiers in Sports and Active Living (2023) Vol. 4
Open Access | Times Cited: 4
Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach
Vaibhav Jain, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2022) Vol. 41, Iss. 1, pp. 85-102
Closed Access | Times Cited: 5
Vaibhav Jain, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2022) Vol. 41, Iss. 1, pp. 85-102
Closed Access | Times Cited: 5
Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease
Marco Greco, Anas Munir, Debora Musarò, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
Marco Greco, Anas Munir, Debora Musarò, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
The Algorithmic uses in AI Influenced Creation of Contemporary Rhymes: A Systematic Review
Kundharu Saddhono, Herman Herman, Rianto Rianto, et al.
(2024), pp. 1539-1544
Closed Access
Kundharu Saddhono, Herman Herman, Rianto Rianto, et al.
(2024), pp. 1539-1544
Closed Access
An Overview of Obstacles in 5G Backhaul and Latest Studies
Rahul Kumar Singh, Zahraa Weaam Qasim, Madi Hashem Attiwi, et al.
(2024), pp. 707-710
Closed Access
Rahul Kumar Singh, Zahraa Weaam Qasim, Madi Hashem Attiwi, et al.
(2024), pp. 707-710
Closed Access
From Words to Algorithms: The to Get Evolution of Indonesia in Terms of Literature via AI Technology
Kundharu Saddhono, Sílvia Rosa, Evi Martiningsih, et al.
(2024), pp. 1568-1572
Closed Access
Kundharu Saddhono, Sílvia Rosa, Evi Martiningsih, et al.
(2024), pp. 1568-1572
Closed Access
The Use of Electromagnetically Wound Based Rotor Constructioned Turbines: An Analysis of Specific uses with its Contradictions
Manali Gupta, Manashree, Ashwini Malviya
(2024), pp. 1-6
Closed Access
Manali Gupta, Manashree, Ashwini Malviya
(2024), pp. 1-6
Closed Access
An Identification and Analysis of Emotion Via Number of Visits and PR In Designing ML Models
Sonal Malhotra, Dharmesh Dhabalia, Ali Ghobash, et al.
(2024), pp. 1252-1256
Closed Access
Sonal Malhotra, Dharmesh Dhabalia, Ali Ghobash, et al.
(2024), pp. 1252-1256
Closed Access
Promoting Reliable Artificial Intelligence by Means of an Ethical Foundation for Trust Evaluation
Divas Tewari, Falah Hassan Abdullah, Israa Jabbar, et al.
(2024), pp. 752-755
Closed Access
Divas Tewari, Falah Hassan Abdullah, Israa Jabbar, et al.
(2024), pp. 752-755
Closed Access
An Intensive Review on 6G and its Future Technological Developments using New Technology Integration
Anil Kumar Sharma, D. Deepa, S Sowmiya, et al.
(2024), pp. 1974-1980
Closed Access
Anil Kumar Sharma, D. Deepa, S Sowmiya, et al.
(2024), pp. 1974-1980
Closed Access
